Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.5B; returns 1 day -2.0%, 1 week +17.6%, 1 year +1.4%.

Viridian Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases, with a primary focus on Thyroid Eye Disease (TED). The company's business model is centered on its pipeline of antibody-based therapies.

Groups VRDN belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Rare Diseases
• Antibody Therapeutics
• Monoclonal Antibodies
• Autoimmune Diseases
• Biopharmaceutical
• Clinical Stage Biopharma
• Life Sciences
• Ophthalmology

VRDN financial model: income statement, cash flow and balance sheet